QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener

QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...

Global Times: Hainan’s Yangpu Port trailblazes advancing high-level opening-up innovations

Hainan FTP launch boosts Yangpu Port with zero-tariff trade, rising throughput and routes, transforming it into a key global shipping and opening-up hub.Beijing, China, Dec. 25, 2025 (GLOBE NEWSWIRE) ...